Literature DB >> 19357179

Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule.

Wing-Kee Lee1, Markus Reichold, Bayram Edemir, Giuliano Ciarimboli, Richard Warth, Hermann Koepsell, Frank Thévenod.   

Abstract

The positively charged fluorescent dyes ethidium (Et(+)) and propidium (Pr(2+)) are widely used as DNA and necrosis markers. Et(+) is cytotoxic and mutagenic. The polyspecific organic cation transporters OCT1 (SLC22A1), OCT2 (SLC22A2), and OCT3 (SLC22A3) mediate electrogenic facilitated diffusion of small (< or =500 Da) organic cations with broad specificities. In humans, OCT2 mediates basolateral uptake by kidney proximal tubules (PT), whereas in rodents OCT1/2 are involved. In mouse kidney, perfused Et(+) accumulated predominantly in the S2/S3 segments of the PT, but not Pr(2+). In cells stably overexpressing human OCTs (hOCTs), Et(+) uptake was observed with K(m) values of 0.8 +/- 0.2 microM (hOCT1), 1.7 +/- 0.5 microM (hOCT2), and 2.0 +/- 0.5 microM (hOCT3), whereas Pr(2+) was not transported. Accumulation of Et(+) was inhibited by OCT substrates quinine, 3-methyl-4-phenylpyridinium (MPP(+)), cimetidine, and tetraethylammonium (TEA(+)). For hOCT1 and hOCT2, the IC(50) values for MPP(+), TEA(+), and cimetidine were higher than for inhibition of previously tested transported substrates. For hOCT2, the inhibition of Et(+) uptake by MPP(+) and cimetidine was shown to be competitive. Et(+) also inhibited transport of 0.1 microM [(3)H]MPP(+) by all hOCT isoforms with IC(50) values between 0.4 and 1.3 microM, and the inhibition of hOCT1-mediated uptake of MPP(+) by Et(+) was competitive. In Oct1/2(-/-) mice, Et(+) uptake in the PT was almost abolished. The data demonstrate that Et(+) is taken up avidly by the PT, which is mediated by OCT1 and/or OCT2. Considering the high affinity of OCTs for Et(+) and their strong expression in various organs, strict safety guidelines for Et(+) handling should be reinforced.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19357179     DOI: 10.1152/ajprenal.90754.2008

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  22 in total

1.  Correlation between Apparent Substrate Affinity and OCT2 Transport Turnover.

Authors:  Alyscia Cory Severance; Philip J Sandoval; Stephen H Wright
Journal:  J Pharmacol Exp Ther       Date:  2017-06-14       Impact factor: 4.030

2.  Ligand-dependent modulation of hOCT1 transport reveals discrete ligand binding sites within the substrate translocation channel.

Authors:  Kelli H Boxberger; Bruno Hagenbuch; Jed N Lampe
Journal:  Biochem Pharmacol       Date:  2018-08-20       Impact factor: 5.858

3.  Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions.

Authors:  Giuliano Ciarimboli; Dirk Deuster; Arne Knief; Michael Sperling; Michael Holtkamp; Bayram Edemir; Hermann Pavenstädt; Claudia Lanvers-Kaminsky; Antoinette am Zehnhoff-Dinnesen; Alfred H Schinkel; Hermann Koepsell; Heribert Jürgens; Eberhard Schlatter
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

4.  A role for the organic anion transporter OAT3 in renal creatinine secretion in mice.

Authors:  Volker Vallon; Satish A Eraly; Satish Ramachandra Rao; Maria Gerasimova; Michael Rose; Megha Nagle; Naohiko Anzai; Travis Smith; Kumar Sharma; Sanjay K Nigam; Timo Rieg
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-15

5.  Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patients.

Authors:  Giuliano Ciarimboli; Cynthia S Lancaster; Eberhard Schlatter; Ryan M Franke; Jason A Sprowl; Hermann Pavenstädt; Vivian Massmann; Denise Guckel; Ron H J Mathijssen; Wenjian Yang; Ching-Hon Pui; Mary V Relling; Edwin Herrmann; Alex Sparreboom
Journal:  Clin Cancer Res       Date:  2012-01-05       Impact factor: 12.531

6.  Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.

Authors:  Yasuto Kido; Pär Matsson; Kathleen M Giacomini
Journal:  J Med Chem       Date:  2011-06-08       Impact factor: 7.446

7.  Multiple mechanisms of ligand interaction with the human organic cation transporter, OCT2.

Authors:  Jaclyn N Harper; Stephen H Wright
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-03

8.  Mouse organic cation transporter 1 determines properties and regulation of basolateral organic cation transport in renal proximal tubules.

Authors:  Eberhard Schlatter; Philipp Klassen; Vivian Massmann; Svenja K Holle; Denise Guckel; Bayram Edemir; Hermann Pavenstädt; Giuliano Ciarimboli
Journal:  Pflugers Arch       Date:  2014-08       Impact factor: 3.657

9.  Substrate-dependent ligand inhibition of the human organic cation transporter OCT2.

Authors:  Mathew Belzer; Mark Morales; Bhumasamudram Jagadish; Eugene A Mash; Stephen H Wright
Journal:  J Pharmacol Exp Ther       Date:  2013-05-24       Impact factor: 4.030

10.  The organic cation transporter 3 (OCT3) as molecular target of psychotropic drugs: transport characteristics and acute regulation of cloned murine OCT3.

Authors:  Vivian Massmann; Bayram Edemir; Eberhard Schlatter; Rouvier Al-Monajjed; Saliha Harrach; Philipp Klassen; Svenja K Holle; Aleksandra Sindic; Marina Dobrivojevic; Hermann Pavenstädt; Giuliano Ciarimboli
Journal:  Pflugers Arch       Date:  2013-08-28       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.